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IQGAP1 and IQGAP3 Serve Individually Essential
Roles in Normal Epidermal Homeostasis and Tumor
Progression
Christine L. Monteleon1, Andrew McNeal1, Elizabeth K. Duperret1, Seung J. Oh1, Emily Schapira1 and
Todd W. Ridky1
IQ motif–containing GTPase-activating protein (IQGAP) scaffolding proteins regulate many essential cellular
processes including growth factor receptor signaling, cytoskeletal rearrangement, adhesion, and proliferation
and are highly expressed in many cancers. Using genetically engineered human skin tissue in vivo, we
demonstrate that diminished, sub-physiologic expression of IQGAP1 or IQGAP3 is sufﬁcient to maintain normal
epidermal homeostasis, whereas signiﬁcantly higher levels are required to support tumorigenesis. To target this
tumor-speciﬁc IQGAP requirement in vivo, we engineered epidermal keratinocytes to express individual IQGAP
protein domains designed to compete with endogenous IQGAPs for effector protein binding. Expression of the
IQGAP1-IQ motif decoy domain in epidermal tissue in vivo inhibits oncogenic Ras-driven mitogen-activated
protein kinase signaling and antagonizes tumorigenesis, without disrupting normal epidermal proliferation or
differentiation. These ﬁndings deﬁne essential non-redundant roles for IQGAP1 and IQGAP3 in the epidermis
and demonstrate the potential of IQGAP antagonism for cancer therapy.
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INTRODUCTION
The progression of invasive neoplasia frequently involves
dysregulation of cellular signals that are integral to normal
processes. Therapeutics against common oncogenic drivers
often directly interfere with central components of core
signaling pathways, and their clinical utility is limited by
toxicity to normal cells. In this regard, blocking cell-signaling
scaffolding molecules, in addition to oncogenic drivers, may
be a promising strategy. As modulators of EGFR and mitogen-
activated protein kinase (MAPK) signaling, IQ motif–containing
GTPase-activating proteins (IQGAPs) may be useful thera-
peutic targets.
IQGAPs are a family of ubiquitously expressed scaffolding
proteins that coordinate signaling pathways by facilitating
physical interactions between effector proteins to enhance
signal transduction (Brown and Sacks, 2009). The IQGAP
family is comprised of three isoforms (IQGAP1, IQGAP2, and
IQGAP3), which each contain multiple protein recognition
domains: the F-actin-binding calponin homology domain; a
polyproline-binding region (WW) that binds ERK 1/2; an IQ
motif (IQM) that binds to MEK1/2, Raf, EGFR, and Calmodu-
lin; the Ras GAP–related domain that binds to Rac1 and
Cdc42; and the C-terminal domain that interacts with
E-cadherin, ß-catenin, APC, and Clip-170 (Figure 1a) (Fukata
et al., 2002; Johnson et al., 2009; White et al., 2009). Through
these interactions, IQGAPs regulate growth factor receptor
signaling, MAPK ﬂux, cell–cell adhesion, cell cycle regulation,
and cytoskeletal rearrangements (Briggs and Sacks, 2003;
White et al., 2012)––all critical cellular processes that are
tightly coordinated both spatially and temporally for proper
epidermal growth and differentiation.
Despite the role that IQGAP scaffolds have in supporting
these key cell functions, IQGAP1-null mice develop normally
(Li et al., 2000). The lack of an overt phenotype suggests the
possibility of functional rescue by another IQGAP isoform(s)
in mice. In this regard, IQGAP3 seems to be the most likely
candidate, as it shares 60% homology to IQGAP1 and has a
relatively broad expression pattern (White et al., 2012).
Although IQGAP3-null murine tissue has not been generated,
RNA interference studies in the mouse epithelial cell line
Eph4 demonstrate that, like IQGAP1, IQGAP3 also facilitates
signaling through MAPK (Nojima et al., 2008). IQGAP2
expression is much more limited and expressed predomi-
nantly in the liver, gastro-intestinal tract, and platelets (Nojima
et al., 2008). IQGAP2 is not expressed in the skin. The effects
of acute IQGAP loss in adult murine or human tissue have
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not been studied but are potentially important to examine as
phenotypes resulting from protein loss in developed tissues
can vary signiﬁcantly from those observed with loss during
embryogenesis. Further, mouse and human tissues may differ
with regard to their speciﬁc IQGAP requirements.
IQGAP1 is upregulated in many human cancers including
lung, colon, liver, breast, glioblastoma, and melanoma (Clark
et al., 2000) and regulates core cellular processes critical for
malignant progression including proliferation, adhesion, and
migration. As progression to invasive neoplasia frequently
involves dysregulation of normal cellular processes rather
than activation of pathways completely lacking in the normal
tissue, targeting central components of dysregulated pathways
often results in high toxicity. As modulators rather than
required core elements of key oncogenic signaling pathways,
IQGAP1 or IQGAP3, may be uniquely poised therapeutic
targets.
In this study, we deﬁne the roles of IQGAP1 and IQGAP3 in
both human epidermal homeostasis and invasive epithelial
cancer, by using genetically deﬁned human skin tissues
maintained in their native, orthotopic location in vivo (Ridky
et al., 2010). Tissues were generated using primary keratino-
cytes expressing short hairpin RNAs against IQGAP1 or
IQGAP3. We show that the effects of IQGAP loss vary with
the extent of the knockdown, as partial knockdown (50–85%)
of either IQGAP1 or IQGAP3 was well tolerated in normal
tissues, whereas more complete knockdown (85–95%) resulted
in marked proliferation arrest and tissue failure in vivoWe also
engineered human tissue grafts to express tumor-associated
oncogenes sufﬁcient to drive squamous cell carcinoma (SCC)
and demonstrate a tumor-speciﬁc requirement for increased
IQGAP1 and IQGAP3 in this cancer context. Finally, we
developed an interfering decoy peptide based on the IQGAP-
IQM domain that selectively inhibits oncogenic Ras activity in
tissue. These ﬁndings establish the requirements of IQGAP1
and IQGAP3 in epidermal homeostasis and cutaneous tumor
progression and establish the potential therapeutic utility of
targeting IQGAPs in human cancer.
RESULTS
IQGAP1 and IQGAP3 are expressed in normal human epidermis
and in epidermal SCC
Both normal human skin and spontaneous human SCC tumor
tissues display robust IQGAP1 and IQGAP3 expression
(Figure 1b). IQGAP1 is located throughout all layers of the
epidermal compartment, whereas IQGAP3 expression is con-
centrated within the proliferative basal cells and is relatively
absent in the post-mitotic suprabasal layers (Figure 1b
and Supplementary Figure S1 online). Within keratinocytes,
IQGAP1 and IQGAP3 are localized throughout the
cytoplasm and are also concentrated at the plasma mem-
brane. This expression and cellular distribution reﬂects the
diversity of scaffolding activities and interacting effector
proteins and is consistent with IQGAP expression patterns in
other tissues (Nabeshima et al., 2002; Berglund et al., 2008).
We were unable to detect IQGAP2 protein in skin tissue or
cultured primary keratinocytes (data not shown), consistent
with its previously established limited tissue distribution
(White et al., 2009, 2012).
IQGAP1 and IQGAP3 are both required for human epidermal
keratinocyte proliferation
To determine the degree to which IQGAP1 and IQGAP3 are
required for normal epidermal function, we generated stable
populations of primary, early passage human IQGAP1 or
IQGAP3 knockdown (IQGAP1i or IQGAP3i) keratinocytes
utilizing lentiviral transduction to drive constitutive short
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Figure 1. IQGAP1 and IQGAP3 are highly expressed in normal human
epidermis and epidermal squamous cell carcinoma. (a) IQGAP1 and IQGAP3
are multidomain scaffolding proteins with highly homologous structural motifs
and the ability to bind a range of cell signaling and cytostructrual molecules.
(b) Cryosections of human normal and SCC tissue were prepared for
immunoﬂuorescence microscopy of IQGAP1 (green), IQGAP3 (red), and
nuclei (blue). Bar= 100 μm. IQGAP1 is expressed throughout the epidermal
compartment of both normal and cancer tissue. IQGAP3 expression is
concentrated within the proliferative basal layer. Keratin 5 (red) and
Keratin 10 (green) differentiation markers are also shown in both normal
and SCC tissue. Bar=100 μm. CHD, calponin homology domain; IQGAP,
IQ motif–containing GTPase-activating protein; SCC, squamous cell
carcinoma.
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hairpin RNA expression. Several lentivectors were used for
each IQGAP to achieve varying levels of knockdown
(Figure 2a and Supplementary Figure S2 online). The pGIPZ,
miR-30 based, IQGAP interference resulted in 50% IQGAP1
protein knockdown and an 85% IQGAP3 protein knock-
down, referred to here as IQ1iMod and IQ3iMod, respectively.
With these levels of knockdown, loss of either IQGAP1 or
IQGAP3 does not impact the expression level of the other
isoform. More complete knockdown was obtained with the
pLKO U6–driven lentivectors, which resulted in IQGAP1 and
IQGAP3 RNA knockdown of 90% and 96%, respectively,
referred to as IQ1iLo and IQ3iLo (Figure 2a and b). In contrast
to the moderate knockdowns, severe depletion of IQGAP1
also resulted in concurrent depletion of IQGAP3 protein. This
is likely a consequence of the proliferative arrest in the IQ1iLo
cells (discussed further below). IQGAP1 protein and transcript
levels remained relatively normal in IQ3iLo cells (Figure 2a
and b and Supplementary Figure S3 online).
Although the IQ1iMod and IQ3iMod keratinocytes are
morphologically indistinguishable from controls, and prolif-
erate normally in culture, the growth of IQ1iLo and IQ3iLo
keratinocytes was markedly inhibited (Figure 2c and Supple-
mentary Figure S2 online). This demonstrates that, although
normal cellular proliferation can be maintained with sig-
niﬁcantly diminished IQGAP1 or IQGAP3, they are not
completely dispensable, nor functionally redundant in this
context. The proliferative defect in primary human keratino-
cytes highlights a phenotypic difference between the human
and the mouse genetic systems. The observation that IQGAP3
expression is lost in the IQ1iLo cells is likely a consequence of
the associated growth arrest, rather than a direct consequence
of IQGAP1 loss itself, as IQGAP3 expression has been
previously shown to be limited to proliferating cells (Nojima
et al., 2008). To conﬁrm that the decrease in IQGAP3 is not
speciﬁcally dependent on IQGAP1 loss, primary keratino-
cytes were mitotically arrested with mitomycin-c. Although
IQGAP1 levels remained robust in mitomycin-c-treated,
non-proliferating cells, IQGAP3 levels dropped precipitously
(Supplementary Figure S1 online).
IQGAP1 and IQGAP3 are both required for EGFR activation and
MAPK signaling
IQGAP scaffolds orchestrate a signaling axis from EGFR
through the MAPK cascade by physically binding to EGFR,
BRaf, MEK1/2, and ERK1/2 and modulating their activities
(Brown and Sacks, 2009; McNulty et al., 2011). In the absence
of this scaffold, IQ1iLo and IQ3iLo cells displayed no detectable
active phospho-EFGR (pEGFR) and also expressed less total
EGFR protein (Figure 2d). This diminished EGFR activation is
not the result of decreased EGFR transcription (Supplementary
Figure S4 online). It is also unlikely to result from decreased
EGFR ligand expression, as the major keratinocyte EGFR ligands
including amphiregulin (Stoll et al., 2010) are only modestly
affected by IQGAP antagonism (Supplementary Figure S4
online), and exogenous EGF is routinely included in the cell
culture media. In agreement with decreased EGFR activity,
IQGAPi was associated with a marked reduction in pERK. IQ1iLo
and IQ3iLo keratinocytes also failed to maintain cyclin-D levels,
consistent with the loss of MAPK signaling (Diehl et al., 1997).
As MAPK signaling ﬂux downstream of EGFR is the primary
mitogenic stimulus for epidermal keratinocytes, loss of this
signaling is likely directly responsible for the proliferative arrest
in IQ1iLo and IQ3iLo cells. Consistent with this, p16 protein was
relatively unchanged (Figure 2d), indicating that the proliferative
arrest likely results from loss of mitogenic signaling rather
than cellular senescence. Further, the lack of proliferation
was not a consequence of a prematurely engaged differentia-
tion or apoptotic program (Supplementary Figure S5 online).
In contrast to IQ1iLo and IQ3iLo cells, IQ1iMod and IQ3iMod
cells proliferated normally in culture without signiﬁcant
changes in MAPK signaling (Figure 2d).
Invasive SCC requires higher levels of IQGAP1 and IQGAP3
than does normal epidermis
The profound proliferative defect in the IQGAPi cells was
somewhat unexpected given the lack of overt phenotype in
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Figure 2. Keratinocyte proliferation and mitogenic signaling require low-
level expression of both IQGAP1 and IQGAP3. (a) Western analysis of
primary human keratinocytes expressing constitutive pGIPZ-mediated shRNA
interference (IQ1iMod and IQ3iMod) or pLKO-mediated knockdowns (IQ1iLo
and IQ3iLo). (b) Quantiﬁcation of the residual IQGAP1 and IQGAP3 protein
expressions of IQ1iMod, IQ3iMod, IQ1iLo, and IQ3iLo keratinocytes. (c) A
proliferation assay reveals that a nearly complete IQGAP knockdown in IQ1iLo
and IQ3iLo keratinocytes completely arrests cell growth, whereas IQ1iMod and
IQ3iMod cells proliferate at rates similar to that of the control (means± SD).
(d) Western analysis demonstrates that IQ1iLo and IQ3iLo cells express
markedly lower levels of both EGFR and pEGFR compared with control or
moderate knockdown cells. There is a corresponding reduction in pERK in
IQ1iLo and IQ3iLo keratinocytes (Stoll et al., 2010). IQGAP, IQ motif–
containing GTPase-activating protein; NS, non-silencing; pERK, phospho ERK;
shRNA, short hairpin RNA.
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the IQGAP1-null mice (Li et al., 2000). To explore the
possibility that this difference was the result of in vitro two-
dimensional (2D) culture versus 3D tissue in vivo, we next
used our human IQGAPi keratinocytes to regenerate 3D
organotypic skin tissues employing native human dermis
with intact basement membrane (Ridky et al., 2010). These
organotypic platforms support keratinocyte stratiﬁcation and
differentiation in vitro that recapitulate the structure and
function of human skin. Engineered tissues can subsequently
be grafted into the orthotopic location on the backs of
immunodeﬁcient mice for long-term in vivo study. Given that
one of the hallmark features of epidermal tissues is a relatively
high rate of basal cell proliferation and continual epidermal
renewal, it was not surprising that attempts to establish 3D
in vitro organotypic or in vivo xenograft skin using the
nonproliferative IQ0iLo and IQ3iLo keratinocytes were
unsuccessful. However, tissues generated using IQ1iMod and
IQ3iMod keratinocytes form functional epidermis both in vitro
and in vivo These tissues display normal basal proliferation
and execute a normal stratiﬁcation and differentiation program
(Figure 3a). Thus, the phenotype of the 3D organotypic
experiments parallels that seen in 2D cultures and highlights
the human requirement for basal maintenance of both
IQGAP1 and IQGAP3 for normal epidermal homeostasis.
After establishing the IQGAP requirements in normal
epidermis, we then explored the role of IQGAP in epidermal
tumorigenesis using a genetically deﬁned, in vivo SCC model
(Lazarov et al., 2002). For this approach, stable populations of
non-silencing or IQGAPiMod keratinocytes were engineered to
express constitutively active oncogenic Ras and CDK4. These
two oncogenic drivers alter centrally acting pathways
frequently deregulated in spontaneous human SCC (Lazarov
et al., 2002; Ridky et al., 2010). When used to generate surface
skin grafts in vivo, oncodriver-expressing keratinocytes harboring
non-silencing short hairpin RNA control formed hyper-
proliferative tumors that degraded the basement membrane
and invaded deeply into supporting stroma-recapitulating
hallmark features of spontaneous human SCC. In contrast,
IQ1iMod and IQ3iMod grafts displayed marked attenuation of
the tumor phenotype (Figure 3b). IQ1iMod and IQ3iMod tissues
were only mildly hyperplastic, with only a few focal areas of
early invasion. The baseline MAPK activation that persists in
IQ1iMod and IQ3iMod keratinocytes (and is sufﬁcient to
support normal epidermis) is insufﬁcient to support the full
oncogenic effects of active Ras. These results indicate that
signiﬁcantly higher levels of IQGAP1 and IQGAP3 are
necessary for the initiation and progression of invasive
epidermal neoplasia than for the maintenance of normal
human skin and that IQGAP may therefore be a useful
therapeutic target for human epidermal cancer. Consistent
with this, IQGAP1-null mice are somewhat resistant to skin
cancer induced by topical carcinogen (7,12-dimethylbenz[a]
anthracene/12-O-tetradecanoylphorbol-13-acetate) applica-
tion (Jameson et al., 2013).
Oncogenic Ras effects are blocked with decoy peptides based
on the IQGAP-IQM domain
The markedly attenuated tumor invasion and proliferation
observed with IQGAP knockdown suggests that IQGAP may
be a useful therapeutic target for cancer. To begin exploring
this possibility, we sought to antagonize IQGAP activity by
targeting its interactions with protein effectors in a domain-
speciﬁc manner. To accomplish this, we constructed ﬁve
lentiviruses, each designed to drive expression of a single
IQGAP structural domain. We hypothesized that expression
of these isolated IQGAP peptide domain “decoys” in
keratinocytes may compete with endogenous IQGAP for
effector binding and interfere with signaling.
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Figure 3. Invasive epidermal squamous cell carcinoma (SCC) requires higher IQGAP1 and IQGAP3 expression than normal epidermis. (a) Moderate IQGAP1
and IQGAP3 knockdowns in normal human epidermal xenografts are well tolerated, with no discernable effects on tissue architecture or maintenance in vivo
(b) Moderate knockdowns of IQGAP1 and three markedly attenuate invasive SCC development in keratinocytes expressing H-RasG12V and CDK4R24C. Control
cancer tissues form thick, hyperplastic, deeply invasive tumors, whereas IQ1iMod and IQ3iMod tissues are minimally hyperplastic and lack signiﬁcant invasion.
Bar=100 μm. hSCC, human squamous cell carcinoma; IQGAPS, IQ motif–containing GTPase-activating proteins.
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To quantitatively determine the degree of ﬁtness advantage
or disadvantage conferred by each of the domains in the
context of intact epidermal tissue, we utilized a multiplexed
competition assay (Figure 4a). In this approach, six different
populations of keratinocytes, each engineered to express a
single IQGAP domain (or luciferase control), along with a
uniquely bar-coded ﬂuorescent protein, were pooled in equal
ratios and used to generate the epidermis in vivo. After
4 weeks of in vivo selection, tissues were harvested and
analyzed. Quantitative PCR was used to determine the relative
representation of each cell population in the ﬁnal resulting
tissue, which was compared with that in the starting cell
mixture. In the context of otherwise normal skin, none of the
decoy peptides resulted in a ﬁtness disadvantage, whereas four
conferred a slight ﬁtness advantage. However, in Ras-driven
SCC tissue, cells expressing the isolated IQM domain displayed
a signiﬁcant ﬁtness disadvantage (16-fold) (Figure 4b). Similar
effects were observed in organotypic in vitro tissues with and
without Ras oncogene challenge (Figure 4c). The expression of
the IQM domain did not strongly alter endogenous expression
of either IQGAP1 or IQGAP3, nor did it affect EGFR expression
in primary keratinocytes (Supplementary Figure S6 online).
Similar inhibitory effects were not observed with any of the
other four IQGAP domain peptides.
To more fully characterize the effects of IQGAP-IQM
expression in human tissue, and to validate the effects seen in
the multiplexed screen, we next expressed the IQM domain
individually in engineered human skin xenografts. IQGAP-
IQM expression in otherwise normal epidermis in vivo had
no discernable effect on skin architecture or morphology
(Figure 5a).
We then explored the effects of this single peptide in the SCC
setting. IQGAP1-IQM keratinocytes were transformed with
oncogenic Ras and CDK4 and used to establish both in vitro
and in vivo organotypic skin tissues. In vitro, Ras-expressing
control tissues are hyperplastic, architecturally disordered, and
degrade basement membrane with deep epithelial cell invasion
into supporting stroma. The IQM decoy peptide signiﬁcantly
limits these oncogenic Ras effects, as tissues are markedly less
hyperplastic and lose invasive capacity (Figure 5b). Consistent
with these in vitro results, IQM expression also inhibits Ras
oncogenic effects in xenografts in vivo. Resulting neoplastic
IQM tissues were markedly less hyperproliferative than controls
(Figure 5c), displayed less architectural disorder, and contained
only small focal areas of modest invasion. In contrast, control
tumors were markedly larger and deeply invasive throughout
the tumor (Figure 5d). Consistent with this signiﬁcantly attenuated
cancer phenotype, MAPK activity downstream of oncogenic Ras
was also markedly reduced in the IQM-expressing grafts, as
evidenced by markedly decreased pERK (Figure 5e). The dimini-
shed size of IQM-expressing tumors is likely the direct result of
the loss of MAPK ﬂux. Correspondingly, IQM-expressing tumors
display a signiﬁcantly lower ki67+ proliferative index than
control (Supplementary Figure S6 online). Diminished IQM-
tumor progression is not the result of increased apoptosis or
premature differentiation (as determined by TUNEL, keratin 10,
and ﬁlaggrin) (Supplementary Figure S6 online).
DISCUSSION
Proteins that are essential for neoplastic transformation, but
relatively dispensable for normal tissue homeostasis, are ideal
cancer targets. Here, we demonstrate in vivo that IQGAP
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requirements are signiﬁcantly higher in neoplastic epidermis
than in normal skin. Further, we demonstrate that IQGAP
antagonism via IQM domain decoys may have potential as a
therapeutic strategy for human cancer. As most human
malignancies require increased Ras–Raf–MEK–ERK signaling,
targeting the MAPK scaffolding function of IQGAPs may be
effective as an orthogonal therapeutic approach to inhibiting
the core Ras–MAPK elements directly.
Although IQGAP downregulation is well tolerated, it seems
that there is a critical minimum expression level of IQGAP1
and IQGAP3 that is required for maintaining primary
keratinocyte proliferation. This demonstrates that endogenous
IQGAP1 and IQGAP3 are not functionally redundant. There is
no compensatory upregulation of one isoform with knock-
down of the other. Although our studies suggest that IQGAP1
and IQGAP3 function similarly in the maintenance of MAPK
activity, they may differ with regard to their other tissue-
context-speciﬁc scaffolding roles, including regulation of
cytoskeletal remodeling proteins. Although IQGAP1 is expressed
throughout the epidermal compartment and tumor, IQGAP3
expression is most prominent within the basal layer of normal
skin and the advancing font of SCC tumors, where there may
be a requirement for higher total levels of collective IQGAP
activity.
The isolated IQM domain likely inﬂuences multiple IQGAP
activities within keratinocytes that together results in less
MAPK activity and attenuation of Ras-driven tumorigenesis.
IQM was designed to interfere with oncogenic Ras signaling
by competing with endogenous full-length IQGAP for binding
to Raf and MEK and thus limiting assembly of the coordinated
signaling complex required for ERK phosphorylation. The
IQM peptide may also inhibit Ras-induced paracrine signaling
at the level of EGFR, a potent mitogenic signal for keratino-
cytes in culture or in tumor formation (Dlugosz et al., 1997)
that signals through Ras–MAPK.
Currently available drugs targeting the MAPK pathway are
small molecule, cell-permeable inhibitors. IQGAPs do not
possess kinase activity and are not cell-surface proteins. Targeting
them inside cells will therefore require a non-traditional
approach. Engineering IQM domain with polyarginine or HIV
TAT protein sequences would potentially allow exogenously
supplied recombinant proteins to permeate tumor tissue. The
feasibility of this strategy was recently demonstrated for an
epitope-tagged, polyarginine-modiﬁed WW domain peptide,
which when continually infused slowed down the growth of
mouse pancreatic cancers and tumor cell lines grown
subcutaneously in immunodeﬁcient mice (Jameson et al.,
2013). Although we included the unmodiﬁed IQGAP
WW domain in our initial screen, we did not detect any
anti-tumor effects in our system. The reasons for this are
unclear but may relate to the addition of polyarginine, or
epitope sequences in the other study, or the use of different
in vivo tumor models.
In summary, our ﬁndings deﬁne non-redundant roles
for IQGAP1 and IQGAP3 in normal human skin and
establish an elevated tumor-speciﬁc IQGAP requirement that
can be targeted to inhibit Ras-driven human cancer growth
in vivo.
MATERIALS AND METHODS
Cell culture
All experiments were conducted using primary keratinocytes isolated
from normal human skin by methods delineated previously (Lazarov
et al., 2002; Ridky et al., 2010). Keratinocytes were cultured in a 1:1
mix of Gibco Keratinocytes-SFM medium+L-glutamine+EGF+BPE
and Gibco Cascade Biologics 154 medium with 1% penicillin/
streptomycin (Invitrogen, Carlsbad, CA). Transduced keratinocytes
were fully selected before the commencement of each experiment.
CDK4/Ras-challenged keratinocytes were transformed prior to the
initiation of 3D cultures.
Lentiviral and retroviral production and transduction
293T- and 293-derivitive Phoenix cells (Swift et al., 2001) were
cultured in DMEM supplemented with 5% fetal bovine serum
containing antibiotic/antimycotic. Lentiviral and retroviral particle
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Figure 5. Expression of the IQGAP1-IQM decoy peptide inhibits invasive
squamous cell carcinoma. (a) IQGAP1-IQM expression does not adversely
affect normal epidermis in vivo, bar=100 μm. (b) IQGAP1-IQM expression
inhibits keratinocyte proliferation and invasion in Ras-expressing neoplastic
skin in vitro, bar=100 μm and in vivo. (c), bar= 250 μm. (d) Relative tumor
cross-section area of xenograft control versus IQGAP1-IQM SCC tumors.
(e) MAPK signaling as indicated by phospho-ERK expression is markedly
diminished in the IQM-expressing tissue, bar=100 μm. IQGAP1, IQ motif–
containing GTPase-activating protein; H&E, hematoxylin and eosin; IQM, IQ
motif; MAPK, mitogen-activated protein kinase; OTC, organotypic culture.
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were generated according to Thermoscientiﬁc (Waltham, MA)
speciﬁcations and as described previously (Lazarov et al., 2002;
Chudnovsky et al., 2005; Ridky et al., 2010). Lentiviral short hairpin
RNA constructs against IQGAP (OpenBiosystems, Lafayette, CO)
were as follows: pGIPZ/sh-IQGAP1 (antisense: 3′-TGATATCCATG
AGATTGAG-5′), pGIPZ/sh-IQGAP3 (antisense: TGTCTTCTAGCACA
TCCTG-5′), pLKO1/sh-IQGAP1 (antisense: 3′-AATGGAAATGTAGATT
ACTGG-5′), and pLKO1/sh-IQGAP3 (antisense: 3′-AACTTATCAGTC
ATGGCGAGG-5′). Additional RNA interference vectors targeting
IQGAP1 at nucleotide position 864–884 (pLKO) and 4,243–4,261
(pGIPZ) and IQGAP3 at nucleotide 2,848–2,866 (pGIPZ) and 4,120–
4,140 (pLKO) were used to validate ﬁndings and displayed similar
effects on keratinocyte growth (Supplementary Figure S2 online).
Individual IQGAP1 protein binding domains and luciferase were
cloned into the pRRL lentivector. For the production of viral particles,
lentiviral constructs were co-transfected with viral packaging
plasmids pCMVΔR8.91 and pUC-MDG into 293T cells using Fugene
6 Transfection Reagent (Promega, Fitchburg, WI).
For oncogenic transformation, 293-derivitive Phoenix cells stably
transfected with H-RasG12V or CDK4R24C were used to generate
retroviral particles. Keratinocytes that were previously transduced
with IQGAP knockdowns, non-silencing controls, or individual
IQGAP domain–expressing constructs were then transformed with
these retroviral particles as described previously (Chudnovsky et al.,
2005; Ridky et al., 2010).
Proliferation assay
Cells were originally plated at 10,000 cells per cm2. At the
indicated time points, cells were trypsinized and manually counted.
Results are represented as the means of three biological repli-
cates (± SD).
Western analysis
Cells were lysed in RIPA Buffer containing 1X protease inhibitors and
1X phosphatase inhibitors (Roche, Branchburg, NJ), and extracts were
analyzed by SDS-PAGE and Western blotting. Primary antibodies
used in this study include IQGAP1 (Millipore, Billerica, MA), IQGAP3
(Abcam, Cambridge, MA), Actin, pEGFR, EGFR, pERK, ERK, and
cyclinD (Cell Signaling, Danvers, MA), and p16 (BD Pharmingen,
San Diego, CA). After incubation with the appropriate secondary
antibody, proteins were detected using either Luminata Crescendo
Western HRP Substrate (Millipore) or ECL Western Blotting Analysis
System (GE Healthcare, Lafayette, CO).
Organotypic culture and skin xenografts
Organotypic skin cultures were established using genetically
engineered keratinocytes expressing IQGAP knockdowns, non-
silencing controls, active Ras and CDK4 oncogenes, and individual
IQGAP1 peptide domains. For each culture, between 8.0×105 and
1.0× 106 keratinocytes were suspended in 80 μl keratinocyte growth
medium, seeded onto devitalized human dermis, and incubated at
37 °C at an air–liquid interface for 3 days prior to xenografting or for
time indicated for in vitro organotypic cultures according to
previously established methods (Chudnovsky et al., 2005; Ridky
et al., 2010; Duperret et al., 2014).
For xenografting, organotypic cultures were surgically grafted onto
the back skin of 5–7-week-old female ICR severe combined
immunodeﬁcient mice (Taconic, Centre Hudson, NY). For each
in vivo experiment, two to three animals were used per condition,
and results were veriﬁed over three experimental replicates.
Engineered tissues were generated by methods delineated previously
(Lazarov et al., 2002; Ridky et al., 2010).
For competition assays (Figure 4a), distinct populations of
keratinocytes were engineered to express calponin homology
domain, WW, IQM, GRD, and RasGAP, or a luciferace control
along with drug selectable markers and identifying barcodes, with or
without oncogenic Ras/CDK4. These keratinocytes were then pooled
in equal ratios and used to establish organotypic cultures, which
were either maintained in vitro or xenografted on mice. To determine
the relative ﬁtness between the keratinocytes, transcript levels of the
non-coding barcode for each of the domain decoys were analyzed
against its relative abundance in the starting cell population by
quantitative PCR. Three biological replicates were performed for
each condition. All experiments involving animals were performed in
accordance with a University of Pennsylvania IACUC–approved
protocol.
Quantitative real-time reverse-transcriptase–PCR
RNA was extracted from cells and tissues according to the RNeasy
Mini Kit protocol (Qiagen, Valencia, CA) and reverse transcribed to
complementary DNA (cDNA) using the High-Capacity RNA to the
cDNA kit (Applied Biosystems, Grand Island, NY). Quantitative
PCR of resulting cDNA was conducted using Power SYBR Green
Master Mix (Applied Biosystems) and gene-speciﬁc primers, in
triplicate, on a ViiA 7 Real-Time PCR System (Life Technologies,
Grand Island, NY). Relative expression was determined using the
2ΔΔ Ct method.
Immunoﬂuorescence microscopy
Whole-mount cryosections were prepared for immunoﬂuorescence
microscopy as previously described (Ridky et al., 2010). Brieﬂy,
slides were ﬁxed in 4% paraformaldehyde or − 20 °C methanol,
permeabilized as required, and blocked with 5% goat serum/
phosphate-buffered saline, followed by incubation with primary
antibodies and secondary antibodies conjugated to ﬂuorophores.
Slides were mounted with Prolong Gold Antifade Reagent with DAPI
(4',6-diamidino-2-phenylindole; Life Technologies). The primary
antibodies used in this study were IQGAP1 and Collagen VII
(Millipore), IQGAP3, Desmogelin-3 (Invitrogen), and Keratin-5
(Covance, Conshohocken, PA).
Immunohistochemistry
Formalin-ﬁxed parafﬁn-embedded tissue sections from xenografts
were stained for pERK protein expression using the peroxidase/
diaminobenzidine-complex method (EXPOSE biotin-free detection
kit, Abcam). Tissue sections were deparafﬁnized and rehydrated. To
retrieve the antigens, tissue sections were microwaved in 10mM
citrate buffer pH 6.0. To quench endogenous peroxidase, tissues
were incubated in 3% H2O2. Afterward, tissues were incubated with
primary antibody to pERK for 3 hours at room temperature. The
secondary antibody, horseradish peroxidase (HRP)-conjugated goat
anti-rabbit, was supplied with the kit and incubated 18 minutes at
room temperature. Following multiple washes in Tris-buffered saline
the antigen–antibody complex was visualized with 3.3% diamino-
benzidine solution. The tissues were counterstained with hematox-
ylin and dehydrated prior to mounting coverslips.
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